We highly recommend enabling Javascript while using the BlackBoxRX site.


Gold Toxicity

RIDAURA® (auranofin) contains gold and, like other gold-containing drugs, can cause gold toxicity, signs of which include: fall in hemoglobin, leukopenia below 4,000 WBC/cu mm, granulocytes below 1,500/cu mm, decrease in platelets below 150,000/cu mm, proteinuria, hematuria, pruritus, rash, stomatitis or persistent diarrhea. Therefore, the results of recommended laboratory work (SeePRECAUTIONS) should be reviewed before writing each RIDAURA prescription. Like other gold preparations, RIDAURA is only indicated for use in selected patients with active rheumatoid arthritis. Physicians planning to use RIDAURA should be experienced with chrysotherapy and should thoroughly familiarize themselves with the toxicity and benefits of RIDAURA.

In addition, the following precautions should be routinely employed:

  1. The possibility of adverse reactions should be explained to patients before starting therapy.
  2. Patients should be advised to report promptly any symptoms suggesting toxicity. (SeePRECAUTIONS—INFORMATION FOR PATIENTS.)

Patient Counseling Information

Package Inserts


Additional Information

Updated January 2018